|
Model Number SPL-PR376 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Fever (1858); Urinary Tract Infection (2120)
|
Event Date 09/29/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Since the literature described "shockpulse-se", olympus selected "spl-pr376" as a representative product.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article doi: 10.1089/end.2022.36001.Abstracts provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
|
Event Description
|
Olympus reviewed the following literature titled "comparison of swiss lithoclast® trilogy and shockpulse-se as energy source in percutaneous nephrolithotomy for staghorn stones: a matched pair analysis." this study aimed to evaluate efficacy of swiss lithoclast trilogy (boston scientific, usa) and shockpulse-se (olympus) in pcnl for staghorn stones in 85 patients.Trilogy had 81.48 % clearance and shockpulse-se had 61.53% clearance at 48 hours in first stage pcnl.18.51% patients of trilogy and 38.46% patients of shockpulse-se required subsequent staged pcnl.Trilogy had 92.59% stone free rate at 3-month follow-up while shockpulse-se had 80.76% stone free rate.As per the study results, trilogy has comparable stone fragmentation rate with shockpulse-se in managing staghorn renal stones.Complications and instrument malfunction were also comparable for trilogy and shockpulse-s.Type of adverse events/number of patients clavien-dindo grade-ii complications -3 (uti with fever) malfunctions suction block - 2 probe breaks - 3 this literature article requires 6 reports.The related patient identifiers are as follows: (b)(6) (for clavien-dindo grade-ii complications), (b)(6) (for suction block 1/2), (b)(6) (for suction block 2/2), (b)(6) (for probe break 1/3), (b)(6) (for probe break 2/3), (b)(6) (for probe break 3/3).This medwatch report is for patient identifier (b)(6).
|
|
Manufacturer Narrative
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes a correction to e4 to provide information that was inadvertently not included on the initial medwatch.Also, new information added to d4 and d8.Olympus will continue to monitor field performance for this device.
|
|
Search Alerts/Recalls
|
|
|